Literature DB >> 20816463

Surgical treatment of cranial neuralgias.

Angelo Franzini1, Paolo Ferroli, Giuseppe Messina, Giovanni Broggi.   

Abstract

The most common types of cranial neuralgias amenable to surgical therapeutic options are trigeminal neuralgia and glossopharyngeal neuralgia, the former having an approximate incidence of 5/100000 cases per year and the latter of 0.05/100000 cases per year. Surgical therapy of these pathological conditions encompasses several strategies, going from ablative procedures to neurovascular decompression, to radiosurgery. The choice of the most appropriate surgical option (which must be taken into account when all conservative treatments have proven to be unsuccessful) has to take into account many factors, the most important ones being neuroradiological evidence of a neurovascular conflict, severity of symptoms, the age and clinical history of the patient, and the patient's overall medical condition. In this chapter we report our experience with the treatment of trigeminal and glossopharyngeal neuralgia, describing the surgical procedures performed and reviewing the most recent aspects on this subject in the past literature.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20816463     DOI: 10.1016/S0072-9752(10)97057-7

Source DB:  PubMed          Journal:  Handb Clin Neurol        ISSN: 0072-9752


  3 in total

Review 1.  Treatments of glossopharyngeal neuralgia: towards standard procedures.

Authors:  Andrea Franzini; Giuseppe Messina; Angelo Franzini; Marcello Marchetti; Paolo Ferroli; Laura Fariselli; Giovanni Broggi
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

Review 2.  Nerve Compression Syndromes in the Posterior Cranial Fossa.

Authors:  Jörg Baldauf; Christian Rosenstengel; Henry W S Schroeder
Journal:  Dtsch Arztebl Int       Date:  2019-01-25       Impact factor: 5.594

3.  Network Analysis of Foramen Ovale Electrode Recordings in Drug-resistant Temporal Lobe Epilepsy Patients.

Authors:  Ancor Sanz-García; Lorena Vega-Zelaya; Jesús Pastor; Cristina V Torres; Rafael G Sola; Guillermo J Ortega
Journal:  J Vis Exp       Date:  2016-12-18       Impact factor: 1.355

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.